390 related articles for article (PubMed ID: 17761370)
1. Humoral responses to oxidized low-density lipoprotein and related bacterial antigens after pneumococcal vaccine.
Nguyen JT; Myers N; Palaia J; Georgopoulos A; Rubins JB; Janoff EN
Transl Res; 2007 Sep; 150(3):172-9. PubMed ID: 17761370
[TBL] [Abstract][Full Text] [Related]
2. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.
Binder CJ; Hörkkö S; Dewan A; Chang MK; Kieu EP; Goodyear CS; Shaw PX; Palinski W; Witztum JL; Silverman GJ
Nat Med; 2003 Jun; 9(6):736-43. PubMed ID: 12740573
[TBL] [Abstract][Full Text] [Related]
3. Purification and structure characterization of the active component in the pneumococcal 22F polysaccharide capsule used for adsorption in pneumococcal enzyme-linked immunosorbent assays.
Skovsted IC; Kerrn MB; Sonne-Hansen J; Sauer LE; Nielsen AK; Konradsen HB; Petersen BO; Nyberg NT; Duus JØ
Vaccine; 2007 Aug; 25(35):6490-500. PubMed ID: 17655983
[TBL] [Abstract][Full Text] [Related]
4. Antibody response to pneumolysin and to pneumococcal capsular polysaccharide in healthy individuals and Streptococcus pneumoniae infected patients.
Huo Z; Spencer O; Miles J; Johnson J; Holliman R; Sheldon J; Riches P
Vaccine; 2004 Mar; 22(9-10):1157-61. PubMed ID: 15003643
[TBL] [Abstract][Full Text] [Related]
5. Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity.
Uddin S; Borrow R; Haeney MR; Moran A; Warrington R; Balmer P; Arkwright PD
Vaccine; 2006 Jul; 24(27-28):5637-44. PubMed ID: 16730399
[TBL] [Abstract][Full Text] [Related]
6. Pneumococcal vaccination may induce anti-oxidized low-density lipoprotein antibodies that have potentially protective effects against cardiovascular disease.
Suthers B; Hansbro P; Thambar S; McEvoy M; Peel R; Attia J
Vaccine; 2012 Jun; 30(27):3983-5. PubMed ID: 22507657
[TBL] [Abstract][Full Text] [Related]
7. Type 6 and 19 pneumococcal polysaccharides coupled to erythrocytes elicit pneumococcal cell wall-specific primary IgM responses and capsular polysaccharide-specific secondary IgG responses.
Milligan GN; Fairchild RL; Sterner KE; Braley-Mullen H
Eur J Immunol; 1990 Mar; 20(3):595-603. PubMed ID: 2318251
[TBL] [Abstract][Full Text] [Related]
8. Prevention of pneumococcal infection in a patient with normal immunoglobulin levels but impaired polysaccharide antibody production.
Cohn JA; Skorpinski E; Cohn JR
Ann Allergy Asthma Immunol; 2006 Nov; 97(5):603-5. PubMed ID: 17165266
[TBL] [Abstract][Full Text] [Related]
9. Antibody responses to pneumococcal capsular polysaccharide: what is being measured?
Goldblatt D; Jadresic LP; Levinsky RJ; Turner MW
Immunodeficiency; 1993; 4(1-4):47-50. PubMed ID: 8167732
[No Abstract] [Full Text] [Related]
10. Selective defect of anti-pneumococcal IgG in a patient with persistent polyclonal B cell lymphocytosis.
Hafraoui K; Moutschen M; Smet J; Mascart F; Schaaf-Lafontaine N; Fillet G
Eur J Intern Med; 2009 May; 20(3):e62-5. PubMed ID: 19393481
[TBL] [Abstract][Full Text] [Related]
11. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X
J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
[TBL] [Abstract][Full Text] [Related]
12. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages.
Kobayashi K; Tada K; Itabe H; Ueno T; Liu PH; Tsutsumi A; Kuwana M; Yasuda T; Shoenfeld Y; de Groot PG; Matsuura E
Lupus; 2007; 16(12):929-38. PubMed ID: 18042586
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants.
Väkeväinen M; Eklund C; Eskola J; Käyhty H
J Infect Dis; 2001 Sep; 184(6):789-93. PubMed ID: 11517443
[TBL] [Abstract][Full Text] [Related]
14. Early atherosclerosis and IgG2 to bacteria are associated with FcgammaRIIa genotype in non-smokers.
Sämpi M; Ukkola O; Päivänsalo M; Kesäniemi YA; Hörkkö S
Eur J Clin Invest; 2009 Jun; 39(6):517-26. PubMed ID: 19490059
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of pneumococcal vaccine in heart transplant recipients.
Blumberg EA; Brozena SC; Stutman P; Wood D; Phan HM; Musher DM
Clin Infect Dis; 2001 Jan; 32(2):307-10. PubMed ID: 11170924
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
[TBL] [Abstract][Full Text] [Related]
17. Immunological responses to pneumococcal vaccine in frail older people.
Ridda I; Macintyre CR; Lindley R; Gao Z; Sullivan JS; Yuan FF; McIntyre PB
Vaccine; 2009 Mar; 27(10):1628-36. PubMed ID: 19100304
[TBL] [Abstract][Full Text] [Related]
18. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
Soininen A; Nohynek H; Lucero M; Jousimies K; Ugpo J; Williams G; Käyhty H;
Vaccine; 2009 May; 27(20):2680-8. PubMed ID: 19428879
[TBL] [Abstract][Full Text] [Related]
19. The effect of T cell independent and cross-reactive antigen on the immune response to pneumococcal conjugate vaccination.
Rabquer B; Smithson SL; Shriner A; Julie Westerink MA
Immunol Lett; 2006 Aug; 106(2):187-90. PubMed ID: 16781780
[TBL] [Abstract][Full Text] [Related]
20. Locally produced anti-phosphorylcholine and anti-oxidized low-density lipoprotein antibodies in gingival crevicular fluid from aggressive periodontitis patients.
Schenkein HA; Berry CR; Burmeister JA; Brooks CN; Best AM; Tew JG
J Periodontol; 2004 Jan; 75(1):146-53. PubMed ID: 15025226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
